Pregabalin for Chronic Pruritus | Therapeutic Cheat Sheet
Chronic pruritus affects 8-16% of the general population and has a profound impact on patient quality of life.1-3Although the symptom of pruritus may originate from a number of underlying etiologies, including metabolic derangements and infectious causes, along with neoplastic, inflammatory, or psychiatric conditions, other cases may be idiopathic in nature.4 Given the diversity of underlying cont …
ANNOUNCING THE FULL SPECTRUM OF DERMATOLOGY: A DIVERSE AND INCLUSIVE ATLAS
Inclusive Derm AtlasThe Full Spectrum of Dermatology:  A Diverse and Inclusive Atlas A visual representation of dermatologic diseases in all skin tones. AVAILABLE SUMMER 2021 Closing the gap A council of dermatology leaders across the country are working together to create a comprehensive atlas that will address what has become a well-documented gap in dermatology education. From resources and programming used i …
Inclusive Derm Atlas
Novel Therapeutics in Atopic Dermatitis
Novel Therapies Atopic DermatitisAtopic dermatitis (AD) is a chronic inflammatory skin disease. The pathogenesis of AD is complex with many mediators involved and can be broken down into 4 categories: Immune dysregulation Abnormal skin barrier Abnormal itch/scratch cycle Abnormal skin microbiome In AD, there is a breakdown in molecular control of the immune system, leading to overproduction and expressi …
Novel Therapies Atopic Dermatitis
Patient Buzz Series: From K-beauty Trends to Psoriasis vs. Eczema
K-beautyThis month’s Patient Buzz includes articles ranging from K-beauty trends, which are skincare products and practices popular in Korea, to differentiating psoriasis from eczema. Review this list of dermatology articles from the consumer press and be ready for your patient’s questions about K-beauty and other skin, hair, and nail trends: Allure: How to prepare for a teledermatology …
K-beauty
Dupilumab Therapeutic Cheat Sheet
DupilumabAtopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …
Dupilumab
error

Enjoy this blog? Please spread the word :)